Consider you are warned - Clinical Study Manager BeOne Employee Review

1.0
12 Nov 2021
Recommend
CEO approval
Business outlook

Pros

Pay higher than most US pharma to attract experienced folks and will attempt to keep you using attractive RSUs with long vesting schedule

Cons

Majority of the negative comments here are true. The company is controlled and directed essentially by leadership team from China who does not follow or respect FDA guidance very well and often make critical mistakes. Lack of standards process, extremely high turnover and always hiring like crazy. Expect you to work late hours to cope with time zone difference and pressure from senior management. US based directors and ADs don’t have real control and are panic driven by Chinese leadership. They survive on asking middle management to shoulder all responsibilities for them and feed them with new ideas and strategies to present.

Explore other reviews about BeOne

5.0
24 Apr 2026
Anonymous employee
Recommend
CEO approval
Business outlook

Pros

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Cons

Fast timelines and global expansion may translate into heavy workload and urgency

5.0
22 Apr 2026
Recommend
CEO approval
Business outlook

Pros

chance to make a bigger impact than at big pharma but not as risky as a small biotech or start up where the company can run out of funding, high pay, flexible hours

Cons

longer work hours, off-hour calls with different regions depending on the role, experiences can vary by group

See reviews by: Helpful|Rating|Date|All